Dynavax Technologies
Price & Volume
Stats
See more52W Range | $9.20-$14.63 |
Market Cap | $1.3B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $330.5M |
Revenue Growth (YoY) | 17.7% |
Gross Profit (12 Mos) | $203.6M |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 19 days ago
CDC vaccine panel voting on hepatitis b shots postponed over confusion
Yahoo Finance • 22 days ago
CDC vaccine panel set to debate hepatitis b shots, childhood immunizations
Yahoo Finance • 23 days ago
Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10
Yahoo Finance • last month
Vaxart, Precigen among biotech gainers after Q3 results
About
CEO | Mr. Ryan Spencer |
CFO | Ms. Kelly MacDonald CPA |
Address | 2100 Powell Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 405 |
